Related Experiment Videos
An enzyme immunoassay for human lymphotoxin
1Central Research Division, Takeda Chemical Industries, Ltd., Osaka, Japan.
Journal of Immunoassay
|January 1, 1989
Summary
A new enzyme immunoassay (EIA) offers highly sensitive and specific detection of human lymphotoxin (hLT). This advanced method significantly outperforms traditional bioassays for quantifying hLT levels.
Area of Science:
- Biochemistry
- Immunology
- Assay Development
Background:
- Human lymphotoxin (hLT) is a crucial cytokine involved in various biological processes.
- Accurate quantification of hLT is essential for understanding its role in health and disease.
- Existing bioassays for hLT lack sufficient sensitivity and specificity.
Purpose of the Study:
- To develop a highly sensitive and specific enzyme immunoassay (EIA) for human lymphotoxin (hLT).
- To compare the performance of the developed EIA with conventional bioassays.
Main Methods:
- A sandwich enzyme immunoassay system was designed using two types of anti-hLT antibodies.
- A mouse monoclonal antibody against recombinant hLT was used as the labeled antibody.
- A rabbit antibody against the carboxyl-terminal portion of hLT was used as the solid-phase antibody.
Main Results:
- The developed EIA demonstrated high sensitivity, detecting less than 50 pg/ml of hLT.
- The EIA exhibited 5-10 times greater sensitivity compared to the conventional L929 cell-lysis bioassay.
- Excellent recovery (101%) and low coefficients of variation (3.3-7.8% intra-assay, 2.9-17.2% inter-assay) were observed.
- A strong correlation (r = 0.93) was found between the EIA and the bioassay.
Conclusions:
- The developed enzyme immunoassay provides a sensitive and specific method for quantifying human lymphotoxin.
- This EIA represents a significant improvement over existing bioassays for hLT measurement.
- The assay shows promise for clinical and research applications requiring accurate hLT quantification.